Rite Aid (RAD) Announces 0.9% Decrease in September Comps
Tweet
Share
E-mailGet Alerts RAD Hot Sheet
Join SI Premium – FREE
Rite Aid Corporation (NYSE: RAD) announces comps were down 0.9% in September.
September front-end same store sales decreased 0.3 percent while pharmacy same store sales, which included an approximate 233 basis points negative impact from new generic introductions, declined 1.2 percent. Prescriptions filled at comparable stores decreased 1.3 percent over the prior-year period.
YTD comps were down 1.2%.
September front-end same store sales decreased 0.3 percent while pharmacy same store sales, which included an approximate 233 basis points negative impact from new generic introductions, declined 1.2 percent. Prescriptions filled at comparable stores decreased 1.3 percent over the prior-year period.
YTD comps were down 1.2%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Radiopharm trial advances to higher dose in HER2+ cancer study
- Radiopharm sets FDA meeting for RAD101 brain metastases trial design
- Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
